Hledání v detailu akcií
Top akcie
NázevNávštěvy
1
1
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN68,8268,861,40
Msft-1,96
Nokia3,153,2215-0,28
IBM-0,56
Mercedes-Benz Group AG76,1676,171,15
PFE0,19
16.04.2024 8:00:02
Indexy online
AD Index online
select
AD Index online
 

  • 15.04.2024
Natural Alt Intl (NASDAQ Cons)
Závěr k 15.4.2024 Změna (%) Změna (USD) Objem obchodů (ks)
6,77 1,20 0,08 2 789
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.04.2024
Popis společnosti
Obecné informace
Název společnostiNatural Alternatives International, Inc.
TickerNAII
Kmenové akcie:Ordinary Shares
RICNAII.O
ISIN-
Poslední známé roční výsledky30.06.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 30.06.2023 317
Akcie v oběhu k 13.02.2024 6 088 813
MěnaUSD
Kontaktní informace
Ulice1535 Faraday Avenue
MěstoCARLSBAD
PSČ92008
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 607 367 700
Fax17607449589

Business Summary: Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company’s CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
Financial Summary: BRIEF: For the six months ended 31 December 2023, Natural Alternatives International, Inc. revenues decreased 31% to $59.2M. Net loss totaled $3.8M vs. income of $2.9M. Revenues reflect Private Label Contract Manufacturing segment decrease of 33% to $55.2M, United States segment decrease of 29% to $41.5M, Outside USA segment decrease of 34% to $17.6M.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICMedicinals And Botanicals
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICCommercial Physical Research



  • Poslední aktualizace: 16.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board of Directors, Chief Executive OfficerMark Ledoux6928.09.2001
President, Chief Operating Officer, SecretaryKenneth Wolf6211.02.2008
Chief Financial OfficerMichael Fortin4501.10.2015